Tekmira to suspend Ebola drug development, focus on hepatitis B

Tekmira Pharmaceuticals Corp., based in Burnaby, B.C., announced on Monday that their TKM-Ebola drug will no longer be produced.

from CBC | Health News http://ift.tt/1fhEAdx